What is Daxor Corporation (DXR) stock price today?

Daxor Corporation (DXR) currently trades at $10.80 per share. The stock has a market capitalization of $59.73M and a P/E ratio of 6.25x.

Is DXR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Daxor Corporation has a Smart Value Score of 45/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the DXR stock price target for 2026?

WallStSmart's 12-month price target for Daxor Corporation is $12.61.

What is Daxor Corporation's revenue and earnings?

Daxor Corporation has trailing twelve-month (TTM) revenue of $26690.00 with profit margins of 34,359.00%. Earnings per share (EPS) is $1.64.

DXR

Daxor Corporation

NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$10.80

+1.41% today

Updated 2026-04-30

Market cap

$59.73M

P/E ratio

6.25

P/S ratio

2,238.07x

EPS (TTM)

$1.64

Dividend yield

—

52W range

$7 – $15

Volume

0.0M

Market cap

$59.73M

P/E ratio

6.25

P/S ratio

2,238.07x

EPS (TTM)

$1.64

Dividend yield

—

52W range

$7 – $15

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

4.7

Growth

5.0

Quality

C+

5.5

Profitability

C+

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$22.50

+108.33%

12-Month target

$12.61

+16.76%

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 34,359.00% — above average

+ ROE 22.50% — strong efficiency

Risks

- Negative free cash flow $-297470.00

- Revenue declining -82.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$6.31M	$34.59M	$2.13M	$503424.00	$26690.00
Net income	$5.18M	$280640.00	$536334.00	$9.17M	$9.54M
EPS	—	—	—	—	$1.64
Free cash flow	$-769302.00	$-3.66M	$25688.00	$-604420.00	$-297470.00
Profit margin	82.06%	0.81%	25.17%	1,821.48%	34,359.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DXR	$59.73M	45	4.7	5.5	6.7	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Daxor Corporation trades at $10.80. representing a P/E of 6.25x trailing earnings. Our Smart Value Score of 45/100 indicates the stock is fair. TTM revenue stands at $26690.00. with profit margins at 34,359.00%.

Frequently asked questions

What is Daxor Corporation's stock price?

Daxor Corporation (DXR) trades at $10.80.

Is Daxor Corporation overvalued?

Smart Value Score 45/100 (Grade C, Sell).

What is the price target of Daxor Corporation (DXR)?

The analyst target price is $22.50, representing +108.3% upside from the current price of $10.80.

What is Daxor Corporation's revenue?

TTM revenue is $26690.00.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2,238.07x

ROE22.50%

Beta0.14

50D MA$10.76

200D MA$11.83

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DXR vs LLY →DXR vs JNJ →DXR vs ABBV →Stock screener →